FDA Inspection 718471 — Byron Chemical Company, Inc.
The FDA completed an inspection of Byron Chemical Company, Inc. on Apr 6, 2011 in Long Island City, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 6, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Long Island City, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)